MOS HOUSE(01653): Wang Chunmei and He Qihang appointed as non-executive directors.
MOS HOUSE (01653) announced that Ms. Wang Chunmei and Mr. He Qihang have been appointed as non-executive directors of the company, effective from December 17, 2025.
MOS HOUSE (01653) announced that Ms. Wang Chunmei and Mr. He Qihang have been appointed as non-executive directors of the company, effective from December 17, 2025.
Related Articles
BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.
RECBIO-B (02179) completes the directed issuance of domestic shares.
TRANSTECH (09963) plans to discount approximately 11.85% of the allotment, with a maximum of 52 million shares, raising approximately HK$244 million net.
BIOSTAR PHARM-B(02563): Yutidelong treatment of brain metastases in breast cancer, the first patient in the United States treated with key clinical research.
RECBIO-B (02179) completes the directed issuance of domestic shares.
TRANSTECH (09963) plans to discount approximately 11.85% of the allotment, with a maximum of 52 million shares, raising approximately HK$244 million net.
RECOMMEND
Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025
What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025
Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025
